Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jan 29, 2026

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
07:05

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: February 23, 2024

3.7K

GDPR: an impediment to research?

Niamh Clarke1,2, Gillian Vale1, Emer P Reeves3,4

  • 1Beaumont Hospital Ethics (Medical Research) Committee, Beaumont Hospital, Dublin, Ireland.

Irish Journal of Medical Science
|February 9, 2019
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Citrullination, a novel posttranslational modification of elastin, is involved in COPD pathogenesis.

American journal of physiology. Lung cellular and molecular physiology·2024
Same author

Augmentation Therapy Decreases Platelet-Neutrophil Aggregates in Alpha-1 Antitrypsin Deficiency.

American journal of respiratory cell and molecular biology·2024
Same author

Neutrophil-Derived Peptidyl Arginine Deiminase Activity Contributes to Pulmonary Emphysema by Enhancing Elastin Degradation.

Journal of immunology (Baltimore, Md. : 1950)·2024
Same author

Monocyte NLRP3 inflammasome and interleukin-1β activation modulated by alpha-1 antitrypsin therapy in deficient individuals.

Thorax·2024
Same author

Targeting of Glycosaminoglycans in Genetic and Inflammatory Airway Disease.

International journal of molecular sciences·2022
Same author

Alpha-1 Antitrypsin Therapy Modifies Neutrophil Adhesion in Patients with Obstructive Lung Disease.

American journal of respiratory cell and molecular biology·2022
Same journal

Transient receptor potential channel 5 knockdown alleviates sevoflurane-induced neural injury by repressing oxidative stress.

Irish journal of medical science·2026
Same journal

A predictive nomogram for relapse risk in children with autoimmune encephalitis.

Irish journal of medical science·2026
Same journal

Real-world antipsychotic prescribing patterns in psychotic disorders: polypharmacy, clozapine, and long-acting injectable use in a tertiary outpatient cohort.

Irish journal of medical science·2026
Same journal

Effects of adding Kinesiotaping to conventional physiotherapy on pain, function, and Kinesiophobia in knee osteoarthritis: A randomized controlled trial.

Irish journal of medical science·2026
Same journal

Neonatal predictors of neurodevelopment: the interplay between APGAR score and neonatal microbiome.

Irish journal of medical science·2026
Same journal

Polypharmacy in glaucoma management: a narrative review.

Irish journal of medical science·2026
See all related articles
This summary is machine-generated.

New Irish health research regulations, influenced by Europe's General Data Protection Regulation (GDPR), pose challenges for clinical research. Clarification is needed to ensure patient access to treatments and support the Irish knowledge economy.

Area of Science:

  • Health Law and Policy
  • Clinical Research Management
  • Data Protection in Healthcare

Background:

  • Recent implementation of Europe's General Data Protection Regulation (GDPR) and Ireland's Health Research Regulations has raised concerns.
  • Ireland's interpretation creates a unique regulatory environment potentially hindering clinical research and patient access to novel treatments.
  • These regulations may negatively impact the attractiveness of Ireland for pharmaceutical research and development.

Purpose of the Study:

  • To examine the specifics of the GDPR and Ireland's Health Research Regulations.
  • To identify challenges faced by clinical researchers under these new regulations.
  • To highlight areas requiring clarification from the Department of Health and the Data Protection Commissioner.

Main Methods:

Keywords:
Biobanks/archival materialCapacity to consentGeneral Data Protection RegulationHealth Research RegulationsRetrospective chart reviews

More Related Videos

Design of a Cyclic Pressure Bioreactor for the Ex Vivo Study of Aortic Heart Valves
07:12

Design of a Cyclic Pressure Bioreactor for the Ex Vivo Study of Aortic Heart Valves

Published on: August 23, 2011

16.3K
Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
08:04

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

13.2K

Related Experiment Videos

Last Updated: Jan 29, 2026

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
07:05

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: February 23, 2024

3.7K
Design of a Cyclic Pressure Bioreactor for the Ex Vivo Study of Aortic Heart Valves
07:12

Design of a Cyclic Pressure Bioreactor for the Ex Vivo Study of Aortic Heart Valves

Published on: August 23, 2011

16.3K
Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
08:04

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

13.2K
  • Review and analysis of European and Irish health research legislation.
  • Examination of the practical implications for clinical researchers in Ireland.
  • Identification of ambiguities and areas needing further guidance.

Main Results:

  • The regulations, as currently applied in Ireland, present significant administrative burdens for clinical researchers.
  • Potential for researchers and institutions to withdraw from clinical research activities.
  • Risk of detriment to patient care and the Irish knowledge economy.

Conclusions:

  • Five recommendations are proposed to mitigate the restrictive aspects of the regulations.
  • Urgent clarification is needed from regulatory bodies to support clinical research.
  • Addressing these issues is crucial for maintaining Ireland's position in clinical research and patient welfare.